Multi-stimuli-responsive chitosan-functionalized magnetite/poly(ε-caprolactone) nanoparticles as theranostic platforms for combined tumor magnetic resonance imaging and chemotherapy
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved..
Chitosan-functionalized magnetite/poly(ε-caprolactone) nanoparticles were formulated by interfacial polymer disposition plus coacervation, and loaded with gemcitabine. That (core/shell)/shell nanostructure was confirmed by electron microscopy, elemental analysis, electrophoretic, and Fourier transform infrared characterizations. A short-term stability study proved the protection against particle aggregation provided by the chitosan shell. Superparamagnetic properties of the nanoparticles were characterized in vitro, while the definition of the longitudinal and transverse relaxivities was an initial indication of their capacity as T2 contrast agents. Safety of the particles was demonstrated in vitro on HFF-1 human fibroblasts, and ex vivo on SCID mice. The nanoparticles demonstrated in vitro pH- and heat-responsive gemcitabine release capabilities. In vivo magnetic resonance imaging studies and Prussian blue visualization of iron deposits in tissue samples defined the improvement in nanoparticle targeting into the tumor when using a magnetic field. This tri-stimuli (magnetite/poly(ε-caprolactone))/chitosan nanostructure could find theranostic applications (biomedical imaging & chemotherapy) against tumors.
Media Type: |
Electronic Article |
---|
Year of Publication: |
2023 |
---|---|
Publication: |
2023 |
Contained In: |
To Main Record - volume:52 |
---|---|
Contained In: |
Nanomedicine : nanotechnology, biology, and medicine - 52(2023) vom: 15. Aug., Seite 102695 |
Language: |
English |
---|
Contributors: |
García-García, Gracia [Author] |
---|
Links: |
---|
Notes: |
Date Completed 01.09.2023 Date Revised 01.09.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.nano.2023.102695 |
---|
funding: |
|
---|---|
Supporting institution / Project title: |
|
PPN (Catalogue-ID): |
NLM359010199 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM359010199 | ||
003 | DE-627 | ||
005 | 20230901232224.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230704s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.nano.2023.102695 |2 doi | |
028 | 5 | 2 | |a pubmed23n1460.xml |
035 | |a (DE-627)NLM359010199 | ||
035 | |a (NLM)37394106 | ||
035 | |a (PII)S1549-9634(23)00046-1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a García-García, Gracia |e verfasserin |4 aut | |
245 | 1 | 0 | |a Multi-stimuli-responsive chitosan-functionalized magnetite/poly(ε-caprolactone) nanoparticles as theranostic platforms for combined tumor magnetic resonance imaging and chemotherapy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 01.09.2023 | ||
500 | |a Date Revised 01.09.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
520 | |a Chitosan-functionalized magnetite/poly(ε-caprolactone) nanoparticles were formulated by interfacial polymer disposition plus coacervation, and loaded with gemcitabine. That (core/shell)/shell nanostructure was confirmed by electron microscopy, elemental analysis, electrophoretic, and Fourier transform infrared characterizations. A short-term stability study proved the protection against particle aggregation provided by the chitosan shell. Superparamagnetic properties of the nanoparticles were characterized in vitro, while the definition of the longitudinal and transverse relaxivities was an initial indication of their capacity as T2 contrast agents. Safety of the particles was demonstrated in vitro on HFF-1 human fibroblasts, and ex vivo on SCID mice. The nanoparticles demonstrated in vitro pH- and heat-responsive gemcitabine release capabilities. In vivo magnetic resonance imaging studies and Prussian blue visualization of iron deposits in tissue samples defined the improvement in nanoparticle targeting into the tumor when using a magnetic field. This tri-stimuli (magnetite/poly(ε-caprolactone))/chitosan nanostructure could find theranostic applications (biomedical imaging & chemotherapy) against tumors | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Chitosan | |
650 | 4 | |a Dual pH- and heat-triggered drug release | |
650 | 4 | |a Magnetic resonance imaging | |
650 | 4 | |a Magnetite | |
650 | 4 | |a Poly(ε-caprolactone) | |
650 | 7 | |a polycaprolactone |2 NLM | |
650 | 7 | |a 24980-41-4 |2 NLM | |
650 | 7 | |a Ferrosoferric Oxide |2 NLM | |
650 | 7 | |a XM0M87F357 |2 NLM | |
650 | 7 | |a Chitosan |2 NLM | |
650 | 7 | |a 9012-76-4 |2 NLM | |
650 | 7 | |a Magnetite Nanoparticles |2 NLM | |
650 | 7 | |a Gemcitabine |2 NLM | |
700 | 1 | |a Caro, Carlos |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Álvarez, Fátima |e verfasserin |4 aut | |
700 | 1 | |a García-Martín, María Luisa |e verfasserin |4 aut | |
700 | 1 | |a Arias, José L |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nanomedicine : nanotechnology, biology, and medicine |d 2005 |g 52(2023) vom: 15. Aug., Seite 102695 |w (DE-627)NLM000057614 |x 1549-9642 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2023 |g day:15 |g month:08 |g pages:102695 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.nano.2023.102695 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
936 | u | w | |d 52 |j 2023 |b 15 |c 08 |h 102695 |
951 | |a AR | ||
952 | |d 52 |j 2023 |b 15 |c 08 |h 102695 |